This weeks other high-risers...
Other announcements include:
Robert Forrester has been promoted to President in addition to COO at Verastem. Dr. Christoph Westphal, Chairman and CEO at Verastem said: "Verastem has rapidly progressed through Robert's dedication and outstanding execution across all aspects of the Company."
Pearl Therapeutics appointing Dr. Michael Riebe as Vice President of Pharmaceutical Development and Research. Riebe comes to Pearl from being the Vice President of Research and Development at iCeutica and has previously held several positional at Merck and GlaxoSmithKline.
